| P50 | author | Angus C Wilson | Q41711326 |
| P2093 | author name string | Linda M Persson | |
| P2860 | cites work | CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex | Q22008610 |
| | Principal role of TRAP/mediator and SWI/SNF complexes in Kaposi's sarcoma-associated herpesvirus RTA-mediated lytic reactivation | Q24550587 |
| | Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8) | Q24650427 |
| | WebLogo: A Sequence Logo Generator | Q27860646 |
| | Notch signalling: a simple pathway becomes complex | Q29555851 |
| | Exploring the DNA binding interactions of the Kaposi's sarcoma-associated herpesvirus lytic switch protein by selective amplification of bound sequences in vitro | Q33234751 |
| | A comprehensive analysis of recruitment and transactivation potential of K-Rta and K-bZIP during reactivation of Kaposi's sarcoma-associated herpesvirus | Q33415884 |
| | A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus | Q33559699 |
| | Early and sustained expression of latent and host modulating genes in coordinated transcriptional program of KSHV productive primary infection of human primary endothelial cells | Q33623056 |
| | An Sp1 response element in the Kaposi's sarcoma-associated herpesvirus open reading frame 50 promoter mediates lytic cycle induction by butyrate | Q33717717 |
| | Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway | Q33737793 |
| | Identification of positive and negative regulatory regions involved in regulating expression of the human cytomegalovirus UL94 late promoter: role of IE2-86 and cellular p53 in mediating negative regulatory function. | Q33782285 |
| | Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line | Q33807199 |
| | Transcription activation of polyadenylated nuclear rna by rta in human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus | Q33837983 |
| | Activation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50). | Q33843421 |
| | Transcription pattern of human herpesvirus 8 open reading frame K3 in primary effusion lymphoma and Kaposi's sarcoma. | Q33844645 |
| | A somatic knockout of CBF1 in a human B-cell line reveals that induction of CD21 and CCR7 by EBNA-2 is strictly CBF1 dependent and that downregulation of immunoglobulin M is partially CBF1 independent | Q33884014 |
| | Notch signaling: the core pathway and its posttranslational regulation | Q34017623 |
| | The herpes simplex virus VP16-induced complex: the makings of a regulatory switch | Q34208918 |
| | Characterization of interactions between RTA and the promoter of polyadenylated nuclear RNA in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. | Q34338900 |
| | Human herpesvirus 8 gene encodes a functional thymidylate synthase | Q34348907 |
| | Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activa | Q34461819 |
| | Target selectivity of vertebrate notch proteins. Collaboration between discrete domains and CSL-binding site architecture determines activation probability | Q34478018 |
| | Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy | Q34683604 |
| | Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma | Q34764819 |
| | More complicated than it looks: assembly of Notch pathway transcription complexes | Q34817647 |
| | Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: dual role of replication and transcription activator | Q35185944 |
| | The role of Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 regulator of transcription activation (RTA) in control of gene expression | Q35196615 |
| | Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 transcriptional activator Rta is an oligomeric DNA-binding protein that interacts with tandem arrays of phased A/T-trinucleotide motifs | Q35803753 |
| | Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1. | Q35829475 |
| | Viral interactions with the Notch pathway | Q35853119 |
| | Essential role of RBP-Jkappa in activation of the K8 delayed-early promoter of Kaposi's sarcoma-associated herpesvirus by ORF50/RTA. | Q35867478 |
| | A single 13-kilobase divergent locus in the Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genome contains nine open reading frames that are homologous to or related to cellular proteins | Q35878042 |
| | Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency | Q36538689 |
| | The Rta/Orf50 transactivator proteins of the gamma-herpesviridae. | Q36647077 |
| | Regulation of KSHV lytic gene expression. | Q36647087 |
| | The recombination signal sequence-binding protein RBP-2N functions as a transcriptional repressor | Q36652805 |
| | Structures of CSL, Notch and Mastermind proteins: piecing together an active transcription complex | Q36678116 |
| | Requirement of a 12-base-pair TATT-containing sequence and viral lytic DNA replication in activation of the Kaposi's sarcoma-associated herpesvirus K8.1 late promoter | Q36954022 |
| | KSHV infection and the pathogenesis of Kaposi's sarcoma | Q37014777 |
| | Alternatively initiated gene 50/RTA transcripts expressed during murine and human gammaherpesvirus reactivation from latency | Q37033176 |
| | Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway. | Q37093134 |
| | Genome-wide identification of binding sites for Kaposi's sarcoma-associated herpesvirus lytic switch protein, RTA. | Q37144643 |
| | NF-kappaB serves as a cellular sensor of Kaposi's sarcoma-associated herpesvirus latency and negatively regulates K-Rta by antagonizing the RBP-Jkappa coactivator. | Q37157187 |
| | The Notch signaling pathway: transcriptional regulation at Notch target genes | Q37376057 |
| | Dissection of the Kaposi's sarcoma-associated herpesvirus gene expression program by using the viral DNA replication inhibitor cidofovir | Q37682897 |
| | Open reading frame 50 protein of Kaposi's sarcoma-associated herpesvirus directly activates the viral PAN and K12 genes by binding to related response elements | Q38291376 |
| | X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency | Q38297437 |
| | Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays | Q38305362 |
| | Recognition sequence of a highly conserved DNA binding protein RBP-J kappa | Q38309890 |
| | Role of Notch signal transduction in Kaposi's sarcoma-associated herpesvirus gene expression | Q38319392 |
| | Discrete enhancer elements mediate selective responsiveness of enhancer of split complex genes to common transcriptional activators | Q38321559 |
| | A functionally distinct TATA box required for late progression through the Epstein-Barr virus life cycle. | Q39581510 |
| | Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus | Q39595507 |
| | Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells | Q39596534 |
| | Octamer-binding sequence is a key element for the autoregulation of Kaposi's sarcoma-associated herpesvirus ORF50/Lyta gene expression | Q39603733 |
| | The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. | Q39860135 |
| | Kaposi's sarcoma-associated herpesvirus RTA activates the processivity factor ORF59 through interaction with RBP-Jkappa and a cis-acting RTA responsive element. | Q39940851 |
| | B cell terminal differentiation factor XBP-1 induces reactivation of Kaposi's sarcoma-associated herpesvirus | Q40110061 |
| | Direct interactions of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta protein with the cellular protein octamer-1 and DNA are critical for specifying transactivation of a delayed-early promoter and stimulating viral reactivati | Q40126113 |
| | Epstein-Barr virus inhibits Kaposi's sarcoma-associated herpesvirus lytic replication in primary effusion lymphomas | Q40155828 |
| | CBF-1 (RBP-J kappa) binds to the PTEN promoter and regulates PTEN gene expression | Q40179833 |
| | Two subclasses of Kaposi's sarcoma-associated herpesvirus lytic cycle promoters distinguished by open reading frame 50 mutant proteins that are deficient in binding to DNA | Q40402402 |
| | Murine gammaherpesvirus 68 Rta-dependent activation of the gene 57 promoter. | Q40459077 |
| | Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression | Q40537413 |
| | RBP-J (CSL) is essential for activation of the K14/vGPCR promoter of Kaposi's sarcoma-associated herpesvirus by the lytic switch protein RTA | Q40546002 |
| | Human cytomegalovirus infection induces cellular thymidylate synthase gene expression in quiescent fibroblasts | Q40685620 |
| | Comparison of the Rta/Orf50 transactivator proteins of gamma-2-herpesviruses. | Q40815022 |
| | On the control of late gene expression in Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). | Q40867898 |
| | Activation of human herpesvirus 8 (HHV-8) thymidine kinase (TK) TATAA-less promoter by HHV-8 ORF50 gene product is SP1 dependent | Q41002173 |
| | Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals | Q41472104 |
| | A Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50 deletion mutant is defective for reactivation of latent virus and DNA replication | Q42150768 |
| | Characterization of the human cytomegalovirus UL75 (glycoprotein H) late gene promoter | Q43717763 |
| | Combinatorial control of transcription: the herpes simplex virus VP16-induced complex | Q44589073 |
| | CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the | Q73802773 |
| | Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein | Q77760836 |
| | The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation | Q81304838 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 14 | |
| P304 | page(s) | 1334-1347 | |
| P577 | publication date | 2009-11-11 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Wide-scale use of Notch signaling factor CSL/RBP-Jkappa in RTA-mediated activation of Kaposi's sarcoma-associated herpesvirus lytic genes | |
| P478 | volume | 84 | |